Journals / Marmara Pharmaceutical Journal / 2018 / Cilt: 22 - Sayı: 2

Synthesis and antiviral activity evaluation of new 4-thiazolidinones bearing an imidazo[2,1-b]thiazole moiety

Pages
237–248
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Neither of the compounds was active against HIV.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A series of new 4-thiazolidinone derivatives were synthesized and evaluated against diverse DNA- and RNA-viruses in mammalian cell cultures.
📊
Key Findings & Data:Some of the compounds were found to exhibit moderate antiviral activity. 3- Propyl-2-[((6-(4-chlorophenyl)imidazo[2,1-b]thiazol-3-yl)acetyl)hydrazono]-5-methyl-4-thiazolidinone 13, displayed modest yet consistent activity against three strains of influenza A virus, including the 2009 pandemic virus A/H1N1 Virginia/ATCC3/2009 (cytotoxicity >100 μM).
💡
Conclusion & Impact:Neither of the compounds was active against HIV.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Özet

A series of new 4-thiazolidinone derivatives were synthesized and evaluated against diverse DNA- and RNA-viruses in mammalian cell cultures. Some of the compounds were found to exhibit moderate antiviral activity. 3- Propyl-2-[((6-(4-chlorophenyl)imidazo[2,1-b]thiazol-3-yl)acetyl)hydrazono]-5-methyl-4-thiazolidinone 13, displayed modest yet consistent activity against three strains of influenza A virus, including the 2009 pandemic virus A/H1N1 Virginia/ATCC3/2009 (cytotoxicity >100 μM). Compounds 6 and 11 displayed activity against vesicular stomatitis virus in HeLa cells (antiviral EC50 values of 9 (cytotoxicity 100 μM) and 2 μM (cytotoxicity 20 μM), respectively). Neither of the compounds was active against HIV.

🔖

Cite This Article

GÜZELDEMİRCİ, N. U., PEHLİVAN, E., NAESENS, L. (2018). Synthesis and antiviral activity evaluation of new 4-thiazolidinones bearing an imidazo[2,1-b]thiazole moiety. Marmara Pharmaceutical Journal, Cilt: 22 - Sayı: 2, 237–248. https://ajindex.com/articles/283599

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Andreani A, Leoni A, Locatelli A, Morigi R, Rambaldi M, Cervellati R, Greco E, Kondratyuk TP, Park EJ, Huang K, Van Breemen RB, Pezzuto JM. Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles. Eur J Med Chem. 2013; 68: 412-421
  2. Ali AR, El-Bendary ER, Ghaly MA, Shehata IA. Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties. Eur J Med Chem. 2014; 75: 492-500
  3. Budriesi R, Ioan P, Leoni A, Pedemonte N, Locatelli A, Micucci M, Chiarini A, Galietta LJV. Cystic Fibrosis: A new target for 4-imidazo[2,1-b]thiazole-1,4-dihydropyridines. J Med Chem. 2011; 54(11): 3885-3894
  4. Ding H, Chen Z, Zhang C, Xin T, Wang Y, Song H, Jiang Y, Chen Y, Xu Y, Tan C. Synthesis and cytotoxic activity of some novel N-pyridinyl-2-(6-phenylimidazo[2,1-b]thiazol-3-yl)acetamide derivatives. Molecules 2012; 17(4): 4703- 4716
  5. Park J, El-Gamal MI, Lee YS, Oh C. New imidazo[2,1-b]thiazole derivatives: Synthesis, in vitro anticancer evaluation, and in silico studies. Eur J Med Chem. 2011; 46(12): 5769-5777
  6. Fidanze SD, Erickson SA, Wang GT, Mantei R, Clark RF, Sorensen BK, Bamaung NY, Kovar P, Johnson EF, Swinger KK, Stewart KD, Zhang Q, Tucker LA, Pappano WN, Wilsbacher JL, Wang J, Sheppard GS, Bell RL, Davidsen SK, Hubbard RD. Imidazo[2,1- b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases. Bioorg Med Chem. 2010; 20(8): 2452- 2455
  7. Juspin T, Laget M, Terme T, Azas N, Vanelle P. TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents. Eur J Med Chem. 2010; 45(2);840-845
  8. Barradas JS, Errea MI, D’Accorso N, Sepúlveda CS, Talarico LB, Damonte EB. Synthesis and antiviral activity of azoles obtained from carbohydrates. Carbohydr Res. 2008; 343(14): 2468-2474
  9. Mas-Prió J, Torrens-Jover A. Substituted imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-HT6 ligands. PCT, World Intellectual Property Organization. 2009; WO 2009/135925 A1
  10. Aissaoui H, Boss C, Gude M, Koberstein R, Sifferlen T. 3-Aza-bicyclo[3.3.0]octane derivatives as orexin receptors antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases. PCT, World Intellectual Property Organization. 2009; WO 2009/004584 A1
  11. Youssef MSK, Ahmed RA, Abbady MS, Abdel-Mohsen SA, Omar AA. Reactions of 4-(2